10-Year Follow-Up: Pembrolizumab Outshines Ipilimumab in Advanced Melanoma
Long-term study shows pembrolizumab's superior efficacy over ipilimumab for advanced melanoma patients.
Multiple Myeloma
4 articles
Acyclovir Prophylaxis Slashes Mucositis Risk in Stem Cell Transplant Patients
Study shows acyclovir prophylaxis significantly reduces oral mucositis in autologous stem cell transplants.
Aponermin Plus Standard Therapy Shows Promise for Relapsed Multiple Myeloma
Phase 3 trial finds aponermin combination improves outcomes in relapsed/refractory multiple myeloma patients
Daratumumab Combo Shows Promise for Relapsed Multiple Myeloma
Study finds adding daratumumab to pomalidomide and dexamethasone improves survival in multiple myeloma
New Myeloma Treatment Shows Promise, But Falls Short of Expectations
Study finds belantamab mafodotin matches standard therapy for multiple myeloma, with fewer infections